The Trouble with Elon
I didn’t set out to become an enemy of the world’s richest man, but I seem to have managed it all the same.
Related Articles
Methods to Explain the Clinical Significance of Health Status Measures
One can classify ways to establish the interpretability of quality-of-life measures as anchor based or distribution based. Anchor-based measures require an independent standard or anchor…
ASCO Guidelines: Treatment of Pleural Mesothelioma Update
Dr. Hedy Kindler joins us on the podcast to discuss the latest update to the treatment of pleural mesothelioma guideline. She discusses the latest changes…
When Disaster Strikes, Is Climate Change to Blame?
Scientists are specifying how much damage climate change is adding to extreme weather events, potentially influencing court cases, insurance claims and public policy
Primary Palliative Care for Emergency Medicine
This cluster randomized clinical trial compares the effect of a multicomponent intervention to initiate palliative care in the emergency department during a preintervention period vs…
Expanding Palliative Care Access—Bridging Gaps in Diverse Clinical Settings
Palliative care has become standard in many inpatient settings, with about three-quarters of US hospitals currently offering such services.1 Although early integration of palliative care…
5 papers about Lung Cancer suggested by Stephen Liu – OncoDaily
5 papers about Lung Cancer suggested by Stephen Liu / cancer, Georgetown University, Hailey M. Hirata, Jacob Sands, Lung cancer, Mehmet Altan, Mehrdad Rakaee,
Survival with Trastuzumab Emtansine in Residual HER2-Positive Breast Cancer | NEJM
Patients with human epidermal growth factor receptor 2 (HER2)–positive early breast cancer with residual invasive disease after neoadjuvant systemic therapy have a high risk of…
